Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 343-346

  Veazey, Ronald S ^a   Shattock, Robin J ^b   Pope, Melissa ^c   Kirijan, J Christian ^a   Jones, Jennifer ^c   Hu, Qinxue ^b   Ketas, Tom ^d   Marx, Preston A ^a   Klasse, Per Johan ^e   Burton, Dennis R ^f   Moore, John P ^d  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c POPULATION COUNCIL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; MEDROXYPROGESTERONE ACETATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B12; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, PASSIVE; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; RNA VIRUSES; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0345471066     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm833     Document Type: Article

References (26)

1. van de Wijgert, J. & Coggins, C. Microbicides to prevent heterosexual transmission of HIV: ten years down the road. BETA 15, 23-28 (2002).
2. Idemyor, V. Promising microbicide approach for prevention of human immunodeficiency virus transmission needs more support. Pharmacotherapy 22, 1074-1076 (2002).
3. Turpin, J.A. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin. Investig. Drugs 11, 1077-1097 (2002).
4. Marx, P.A. et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2, 1084-1089 (1996).
5. Harouse, J.M., Gettie, A., Tan, R.C., Blanchard, J. & Cheng-Mayer, C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284, 816-819 (1999).
6. Harouse, J.M. et al. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3. J. Virol. 75, 1990-1995 (2001).
7. Shattock, R.J., Griffin, G.E. & Gorodeski, G.I. in vitro models of mucosal HIV transmission. Nat. Med. 6, 607-608 (2000).
8. Burton, D.R. et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027 (1994).
9. Greenhead, P. et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74, 5577-5586 (2000).
10. Frank, I. & Pope, M. The enigma of dendritic cell-immunodeficiency virus interplay. Curr. Molec. Med. 2, 229-248 (2002).
11. Parren, P.W. et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75, 8340-8347(2001).
12. Hu, J., Gardner, M.B. & Miller, C.J. Simian Immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087-6095 (2000).
13. Miller, C.J. & Shattock, R.J. Target cells in vaginal HIV transmission. Microbes Infect. (in the press).
14. Parren, P.W. & Burton, D.R. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77, 195-262 (2001).
15. Haase, A.T. The pathogenesis of sexual mucosal transmission and early stages of infection: obstacles and a narrow window of opportunity for prevention. AIDS 15 (suppl. 1), S10-S15 (2001).
16. Pope, M. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994).
17. Sherwood, J.K. et al. Residence half-life of IgG administered topically to the mouse vagina. Biol. Reprod. 54, 264-269 (1996).
18. Saltzman, W.M., Sherwood, J.K., Adams, D.R., Castle, P. & Haller, P. Long-term vaginal antibody delivery: delivery systems and biodistribution. Biotechnol. Bioeng. 67, 253-264 (2000).
19. Vernazza, P.L., Eron, J.J., Fiscus, S.A. & Cohen, M.S. Sexual transmission of HIV: infectiousness and prevention. AIDS 13, 155-166 (1999).
20. Cohen, M.S. et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349, 1868-1873 (1997).
21. Chakraborty, H. et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 15, 621-627 (2001).
22. Gupta, P. et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J. Virol. 71, 6271-6275 (1997).
23. Dyer, J.R. et al. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J. Virol. Meth. 60, 161-70 (1996).
24. Gray, R.H. et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153 (2001).
25. Burton, D.R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2, 706-713 (2002).
26. Dove, A. Uncorking the biomanufacturing bottleneck. Nat. Biotech. 20, 777-779 (2002).